Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07043712 · ClinicalTrials.gov registry record · NA
Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants
A NA study of Metabolic Syndrome and Microbial Colonization, sponsored by University of Missouri-Columbia.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT07043712: Active NA study of Metabolic Syndrome and Microbial Colonization, sponsored by University of Missouri-Columbia.
NCT07043712 is a NA study of Metabolic Syndrome and Microbial Colonization that is active but no longer recruiting, run by University of Missouri-Columbia. The registered enrollment target is 44 participants, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07043712, a NA study of Metabolic Syndrome and Microbial Colonization, is active but no longer recruiting, sponsored by University of Missouri-Columbia.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to investigate the effects of pulse consumption versus no pulse consumption on the gut microbiome, meal satiety, and short-chain fatty acid metabolomics.
Primary Outcome
assessed via 16s rRNA gene sequencing from fecal samples collection
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT High pulse consumption
Study Locations (1)
Missouri
- University of Missouri - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2023-02-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT07043712 still lists
NCT07043712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,205-participant average among 102 other Metabolic Syndrome trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Metabolic Syndrome appearing as the primary indexed condition, and to 1 intervention - of which High pulse consumption is the first listed.
NCT07043712 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT07043712 about?
NCT07043712 is a clinical study titled "Effects of Pulse Consumption, Gut Microbiome, and Appetite in Healthy Participants". The purpose of the study is to investigate the effects of pulse consumption versus no pulse consumption on the gut microbiome, meal satiety, and short-chain fatty acid metabolomics.
What is the current status of trial NCT07043712?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2023-02-01. Estimated completion is 2026-12-31.
What conditions does trial NCT07043712 study?
This clinical trial studies the following conditions: Metabolic Syndrome, Microbial Colonization.
What interventions are being tested in trial NCT07043712?
The interventions under investigation include: High pulse consumption (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07043712?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07043712 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07043712's enrollment target sits among peer trials
44 64th of 102 higher than 38 of 102 other Metabolic Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Animal and Plant Proteins and Glucose Metabolism
RECRUITING · NA
-
VR Stimulation of Exercise Response in Sedentary Humans
RECRUITING · NA
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI